Abstract Solriamfetol (JZP‐110), a selective dopamine and norepinephrine reuptake
inhibitor with wake‐promoting effects, is renally excreted∼ 90% unchanged within 48 hours …

Sleep apnea is a condition with significant health risks and increased risk of mortality and is
prevalent in patients with chronic kidney disease. This paper describes the detrimental …

Background: Obstructive sleep apnea (OSA) is prevalent in patients with type 2 diabetes, but
the influence of OSA on diabetes complications is not clear. We aimed to investigate the …

Chronic kidney disease (CKD) is caused by hypoxia in the renal tissue, leading to
inflammation and increased migration of pathogenic cells. Studies showed that leukocytes …

Sudden Cardiac Death (SCD) is the leading cause of cardiovascular death in dialysis
patients. This review discusses potential underlying arrhythmic mechanisms of SCD in the …

Background The aim of this systematic review and meta-analysis was to summarize the
association of obstructive sleep apnea (OSA) with renal outcome. Methods Our study …

Abstract Study Objectives Nocturnal hypoxemia (NH) in obstructive sleep apnea (OSA) is
associated with renal renin–angiotensin–aldosterone system (RAAS) up-regulation and loss …

Background Sleep apnea is common and associated with poor outcome in severe chronic
kidney disease, but validated screening tools are not available. Our objectives were to …

In patients with chronic kidney disease (CKD) and kidney transplant recipients who continue
to have some degree of CKD, the prevalence of sleep-related disorders is very high …

Pulmonary hypertension (PH) secondary to chronic kidney disease (CKD) is common, but in
stages 1-3 CKD patients, it remains unclear. We sought to evaluate the prevalence of PH …